Cyfuse Biomedical KK (TSE:4892) Total Assets : 円3,844.75 Mil (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Cyfuse Biomedical KK Total Assets?

Cyfuse Biomedical KK's Total Assets for the quarter that ended in Jun. 2024 was 円3,844.75 Mil.

During the past 12 months, Cyfuse Biomedical KK's average Total Assets Growth Rate was 39.30% per year. During the past 3 years, the average Total Assets Growth Rate was 40.40% per year.

During the past 4 years, Cyfuse Biomedical KK's highest 3-Year average Total Assets Growth Rate was 40.40%. The lowest was 40.40%. And the median was 40.40%.

Total Assets is connected with ROA %. Cyfuse Biomedical KK's annualized ROA % for the quarter that ended in Jun. 2024 was -23.02%. Total Assets is also linked to Revenue through Asset Turnover. Cyfuse Biomedical KK's Asset Turnover for the quarter that ended in Jun. 2024 was 0.00.

Cyfuse Biomedical KK Total Assets Historical Data

The historical data trend for Cyfuse Biomedical KK's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyfuse Biomedical KK Total Assets Chart

Cyfuse Biomedical KK Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Total Assets

2,196.21

2,646.23

4,815.34

4,214.81

Cyfuse Biomedical KK Quarterly Data
	Dec20	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Total Assets	Get a 7-Day Free Trial						4,386.41	4,172.12	4,214.81	3,903.84	3,844.75

Cyfuse Biomedical KK Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Cyfuse Biomedical KK's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	3203.469	+	1011.34
	=	4,214.81

Cyfuse Biomedical KK's Total Assets for the quarter that ended in Jun. 2024 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2024 )	+	Total Liabilities (Q: Jun. 2024 )
	=	2931.032	+	913.719
	=	3,844.75

Cyfuse Biomedical KK (TSE:4892) Total Assets Explanation

Total Assets is connected with ROA %.

Cyfuse Biomedical KK's annualized ROA % for the quarter that ended in Jun. 2024 is

ROA %	=	Net Income (Q: Jun. 2024 )	/	( (Total Assets (Q: Mar. 2024 )	+	Total Assets (Q: Jun. 2024 ))	/ count )
	=	-891.744	/	( (3903.842	+	3844.751)	/ 2 )
	=	-891.744	/	3874.2965
	=	-23.02 %

Note: The Net Income data used here is four times the quarterly (Jun. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Cyfuse Biomedical KK's Asset Turnover for the quarter that ended in Jun. 2024 is

	Asset Turnover
=	Revenue (Q: Jun. 2024 )	/	( (Total Assets (Q: Mar. 2024 )	+	Total Assets (Q: Jun. 2024 ))	/ count )
=	7.297	/	( (3903.842	+	3844.751)	/ 2 )
=	7.297	/	3874.2965
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Cyfuse Biomedical KK Total Assets Related Terms

Thank you for viewing the detailed overview of Cyfuse Biomedical KK's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyfuse Biomedical KK Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cyfuse Biomedical KK (TSE:4892) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-5-27, Mita, West Wing-1st Floor. Sumitomo Fudosan Mita Twin Building, Minato-ku, Tokyo, JPN

Website

https://www.cyfusebio.com

Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine related products.

Cyfuse Biomedical KK Headlines

No Headlines